This Anti-Aging Drug is Disrupting a $600 Billion Industry
Dr. Alan Kaplin, Chief Scientific Officer of MyMD, joins Cheddar Innovates to discuss how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases.
More Videos
Swift Strategy: Ten Power Moves from Taylor Every Business (and Person) Can Learn From
Sinéad O’Sullivan explores ten strategic lessons from Taylor Swift’s empire in her new book Good Ideas and Power Moves—dropping September 9, 2025.
SIRI Co-Creator on Leading Cognizant's AI Push
SIRI co-creator Babak Hodjat, now CTO of AI at Cognizant, shares insights on AI’s evolution and how Cognizant is building powerful agents for Fortune 500 firms.
U.S. Private Payrolls Fall by 33K in June, Shaking Labor Market Optimism
Mark Hamrick of Bankrate discusses the jobs market, AI's growing impact on employment, and how markets are reacting to today’s surprising payroll data.
Will Converting Empty Office Buildings Solve New York City's Housing Crisis?
An exclusive look inside NYCs office-to-residence conversion boom and how these ambitious projects may provide a blueprint for addressing housing shortages
Peach & Lily CEO On Going From K‑Beauty Pioneer to 2025’s Skincare Brand of the Year
Alicia Yoon, CEO of Peach & Lily, explores K‑Beauty’s rise, their plant‑powered innovation process & the popularity of the glass skin trend. Watch!
Pharma Stocks Soar Amid Medicaid Cuts and Trump’s Price Pressure — Here’s Why
Amanda Chu of POLITICO reveals how lawmakers are betting millions on pharma stocks even as Trump threatens tariffs and demands steep drug price cuts. Watch!
